Abstract
The design and fabrication of transdermal system is an art. Out of many transdermal systems, the introduction of Drug-in-adhesive drug delivery executes close contact of the carrier with stratum corneum to deliver active molecules across the skin and then into the systemic circulation. Thus, aspect of adhesives in transdermal is vital parameter for fabrication design with respect to safety, efficacy and quality of transdermal drug delivery system. Drug-in-adhesive transdermal patch, prevents partial loss of active drug during process involved in manufacturing and drying of the patches. The optimization of the adhesive properties exhibits an important challenge during pharmaceutical development on the side of minimizing the uncertainty of adhesion failure in practice. This article provides groundwork for understanding general properties of pressure sensitive adhesives (PSA) and utilization in the development of transdermal patches. The manuscript summarizes most extensive methods to measure adhesive properties in the time of development studies.
Keywords: Drug-in-adhesive, pressure sensitive adhesives, rheology, transdermal, viscoelastic.
Drug Delivery Letters
Title:Aspects of Pressure Sensitive Adhesives in Fabricating Drug-in-Adhesive Transdermal Therapeutic Systems
Volume: 7 Issue: 1
Author(s): Niharika Lal, Pragya Yadav, Vaibhav Rastogi, Anurag Verma and Navneet Verma
Affiliation:
Keywords: Drug-in-adhesive, pressure sensitive adhesives, rheology, transdermal, viscoelastic.
Abstract: The design and fabrication of transdermal system is an art. Out of many transdermal systems, the introduction of Drug-in-adhesive drug delivery executes close contact of the carrier with stratum corneum to deliver active molecules across the skin and then into the systemic circulation. Thus, aspect of adhesives in transdermal is vital parameter for fabrication design with respect to safety, efficacy and quality of transdermal drug delivery system. Drug-in-adhesive transdermal patch, prevents partial loss of active drug during process involved in manufacturing and drying of the patches. The optimization of the adhesive properties exhibits an important challenge during pharmaceutical development on the side of minimizing the uncertainty of adhesion failure in practice. This article provides groundwork for understanding general properties of pressure sensitive adhesives (PSA) and utilization in the development of transdermal patches. The manuscript summarizes most extensive methods to measure adhesive properties in the time of development studies.
Export Options
About this article
Cite this article as:
Lal Niharika, Yadav Pragya, Rastogi Vaibhav, Verma Anurag and Verma Navneet , Aspects of Pressure Sensitive Adhesives in Fabricating Drug-in-Adhesive Transdermal Therapeutic Systems, Drug Delivery Letters 2017; 7 (1) . https://dx.doi.org/10.2174/2210303107666170203123445
DOI https://dx.doi.org/10.2174/2210303107666170203123445 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Physiopathological Roles of P2X Receptors in the Central Nervous System
Current Medicinal Chemistry Platelet Hyperreactivity and Stent Thrombosis in Patients Undergoing Coronary Stenting
Current Vascular Pharmacology Peripartum Cardiomyopathy: An Intriguing Challenge. Case Report with Literature Review
Current Cardiology Reviews Neuroprotection by Methylene Blue in Cerebral Global Ischemic Injury Induced Blood-Brain Barrier Disruption and Brain Pathology: A Review
CNS & Neurological Disorders - Drug Targets Chemistry, Biological Properties and SAR Analysis of Quinoxalinones
Mini-Reviews in Medicinal Chemistry Targeting the Role of Astrocytes in the Progression of Alzheimers Disease
Current Signal Transduction Therapy Anti-Inflammatory Effects of C-Peptide Prevent Endothelial Dysfunction in Type 1 Diabetes
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Author Index to Volume 1
Current Vascular Pharmacology Cardiac Dys-Synchronization and Arrhythmia in Hyperhomocysteinemia
Current Neurovascular Research An Insight into the Therapeutic Potential of Major Coffee Components
Current Drug Metabolism Blood Pressure Management in Metabolic Syndrome
Current Hypertension Reviews P2Y12 Receptor Antagonists: Which One to Choose? A Systematic Review and Meta-Analysis
Current Pharmaceutical Design Carotid and Vertebral Arterial Variations in Alzheimer's Disease
Current Alzheimer Research The Role of ROS and RNS in Regulating Life and Death of Blood Monocytes
Current Pharmaceutical Design Fenofibrate and Telmisartan in the Management of Abdominal Aortic Aneurysm
Current Drug Targets Clinical Development of Inhibitors of the Insulin-like Growth Factor Receptor in Oncology
Current Drug Targets Self Managing Heart Failure in Remote Australia - Translating Concepts into Clinical Practice
Current Cardiology Reviews Suppression of Glial HO-1 Activitiy as a Potential Neurotherapeutic Intervention in AD
Current Alzheimer Research Anticancer Mammalian Target of Rapamycin (mTOR) Signaling Pathway Inhibitors: Current Status, Challenges and Future Prospects in Management of Epilepsy
CNS & Neurological Disorders - Drug Targets 3,4-Dihydroxyphenylacetaldehyde: A Potential Target for Neuroprotective Therapy in Parkinsons Disease
Current Drug Targets - CNS & Neurological Disorders